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Abstract
Background: Most studies providing data on survival in patients with atherosclerosis only address a single disease
site: heart, brain or legs. Therefore, our objective was to determine risk of death after first hospital admission for
atherosclerotic disease located at different sites.
Methods: A nationwide cohort of patients hospitalized for the first time for acute myocardial infarction (AMI),
peripheral arterial disease of the lower extremities (PAD) or ischemic stroke was identified through linkage of
national registers. The mortality rate in AMI patients was compared to mortality rate in ischemic stroke and PAD
patients by estimating relative risks (with 95%CI). Cox’s proportional hazard models were used to estimate sex
differences in risk of death.
Results: Case fatality was high for ischemic stroke patients (men:21.0%, women:23.8%) and AMI patients
(men:12.7%, women:20.9%) though low for PAD patients (men:2.4%, women:3.5%). The five-year risk of death was
similar for male AMI compared to PAD patients (men: RR1.04; 95%CI 0.98-1.11). The risk of death for ischemic stroke
patients remained the highest though the differences with AMI and PAD patients attenuated.
Conclusions: The dynamics of mortality over follow-up time clearly differ between atherosclerotic diseases, located
at different vascular beds. The risk of death increases considerably over follow-up time for PAD patients, and
5 years after first hospital admission the differences in risks of death between AMI- and PAD patients and between
AMI- and ischemic stroke patients have largely attenuated. Clinicians should be aware of these dynamics of
mortality over follow-up time to provide optimal secondary prevention treatment.
Background
Atherosclerosis is a systemic disease leading to various
symptoms and clinical events. Acute myocardial infarc-
tion (AMI), ischemic stroke and peripheral arterial dis-
ease of the lower extremities (PAD) are common
atherosclerotic manifestations, by which the coronary
arteries, carotid arteries and peripheral arteries of the
lower extremities respectively, play a major role. In
recent decades, clinical and population-based studies
have provided extensive data on the prognosis of patients
diagnosed with atherosclerosis [1]. These data primarily
address the prognosis of one manifestation of athero-
sclerotic disease rather than different manifestations of
atherosclerosis [2,3]. Several studies have reported asso-
ciations of cardiovascular risk factors with progression of
atherosclerosis [4,5], although the association of the risk
factors with progression of atherosclerosis is inconsistent
across different vascular beds [6]. This might suggest that
prognosis of patients diagnosed with atherosclerosis may
depend on the location of the vascular bed where athero-
sclerosis predominantly becomes manifest.
In a previous study, where we used parts of the data
from the present study, we investigated long-term prog-
nosis of PAD and compared mortality among first hos-
pitalized PAD patients with mortality among patients
first hospitalized for stroke and AMI. We reported that
five-year death rate was somewhat higher among stroke
patients and almost similar for PAD and AMI patients
[7]. Caro et al. [8] investigated potential risk factors for
PAD mortality and presented long term survival among
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fering from stroke and AMI. They reported that the
crude five-year death rate among patients diagnosed
with PAD was lower than death rates among patients
diagnosed with stroke, but higher than death rates
among patients diagnosed with AMI. These studies sug-
gest that there may be a different prognosis per manifes-
tations of atherosclerosis. However, these studies did not
include short-term prognosis [7] or did not provide age-
and sex-specific mortality [8], despite the evidence that
mortality depends on age and gender. The purpose of
the present study, therefore, was to estimate both
detailed short-term and long-term mortality risks, strati-
fied by age and gender, in a large, nationwide cohort of
patients first hospitalized for AMI, ischemic stroke and
PAD.
Methods
For the present study, cohorts were drawn from 1995,
1997 and 2000. The choice of years was pragmatic at
the time the project was initiated in 2001. The total
population of the Netherlands in 1995, 1997 and 2000
was 15,424,122 (men 7,627,428, women 7,796,640),
15,567,107 (men 7,696,803, women 7,870,304) and
15,863,950 (men: 7,846,317, women: 8,017, 633), respec-
tively. Approximately 14% of the population was older
than 65 years. To construct a cohort of patients
admitted for the first time due to ischemic stroke, AMI
and PAD, information from the national Hospital Dis-
charge Register (HDR) and the Population Register (PR)
were linked. Information on cause of death has been
derived from the Cause of Death Register of Statistics
Netherlands. The registers and linkage procedures have
been described in detail previously for a cohort of acute
myocardial infarction [9] and stroke patients [10].
Cohort enrolment
All hospital admissions for acute myocardial infarction
(AMI) between January 1
st and December 31
st 1995,
(ICD-9-CM code 410, ICD-10-CM code I21) and all
hospital admissions for ischemic stroke (ICD-9-CM
code 434, 436, ICD-10-CM code I63) and peripheral
arterial disease of the lower extremities (PAD) (ICD-9-
CM code 443.9, ICD-10-CM code I73.9) between Janu-
ary 1
st and December 31
st 1997 and January 1
st and
December 31
st 2000 respectively, were selected. No
information on severity of disease was available. There-
f o r e ,w ea s s u m e dt h a tP A Dp a t i e n t sd i a g n o s e dw i t h
ICD-9 code 443.9 (peripheral vascular disease unspeci-
fied, intermittent claudication not otherwise specified
(NOS). Peripheral: angiopathy NOS, vascular disease
NOS, Spasm of artery. Excluded are atherosclerosis of
the arteries of the extremities and spasm of cerebral
artery) represents patients hospitalized with moderate/
severe claudication, ischemic rest pain and ulceration or
gangrene (Fontaine stage IIb, III and IV respectively), as
these patients have an indication for surgical interven-
tions [11].
By merging with the PR, only those patients with a
unique combination (linkage variables date of birth, sex
and numerical part of postal code) were selected. Next,
the first hospital admissions in 1995 for AMI and in
1997 and 2000 for ischemic stroke and PAD were
selected. To identify first admissions, the file was
merged with a file in which, through the same linkage
procedures, information was collected on hospital
admissions that occurred previously (1991-1995, 1995-
1997 and 1995-2000 respectively) for the same condi-
tion. For the years 1991-1994 a different - and slightly
less reliable - linkage procedure was used, because the
digital PR only started in 1995 [12]. Those with a pre-
vious admission for the same condition were excluded,
for example, those with a previous hospitalization for
cerebrovascular accident (CVA) were excluded from the
ischemic stroke cohort, but not from the cohorts dealing
with PAD or AMI. This approach left a cohort of
patients admitted to hospital for the first time because
o ft h eo c c u r r e n c eo fi s c h e m i cs t r o k e ,P A Do rA M I .
Finally, the cohort was linked with the Cause of Death
Register to obtain information on date and cause of
death (in-hospital and out-of-hospital) during follow-up.
Patients were censored if they migrated out of the Neth-
erlands during follow-up.
Comorbidity
The presence of comorbidity (cardiovascular diseases
(ICD-9-CM codes 390-459) or diabetes mellitus (ICD-9-
CM code 250)) was determined on the basis of the dis-
charge diagnosis of previous hospital admissions or on
the basis of a secondary diagnosis at the moment of the
index admission.
No information on risk factors (hypertension, smok-
ing) or medication use was available in the register.
Data analysis
Analyses were performed for AMI, ischemic stroke and
PAD. Survival time was calculated as the time from the
initial admission date in 1995 for AMI and 1997 or
2000 for ischemic stroke and PAD, to the date of death
from any cause, or to the date that a patient was cen-
sored, whichever came first. The 28-day case-fatality,
1-year and long-term (5-year) mortality was computed
by age and gender according to the actuarial life table
method and expressed as percentages. To make results
comparable with other community-based studies, the
overall rates were adjusted to the European standard
population [13]. The 1-year and long-term (5-year) mor-
tality was also computed for patients who survive for at
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models were used to study gender differences in mortal-
ity at 28 days, 1 year and 5 years. For each period, a
model was used to adjust for age. Results were pre-
sented as hazard ratios (with 95%CI). The mortality rate
in AMI patients was compared to the mortality rate in
ischemic stroke patients and PAD patients by calculating
relative risks (with 95%CI). Data were analyzed with
SPSS software, version 14.0 (SPSS Inc, Chicago, Illinois,
USA).
Approval for the use of the anonymized patient data
was covered by a general agreement between Statistics
Netherlands and Dutch Hospital Data (DHD). Addition-
ally, the Dutch association of hospitals (NVZ) and
Dutch federation of University Hospitals (NFU)
approved the use of the hospital registration data for
this study. No separate ethical approval was necessary
for the use of these data. All analyses were performed in
accordance with privacy legislation in the Netherlands
[14].
Results
More men than women were hospitalized for first AMI
(14,463 men, 7,102 women) in 1995 and PAD (2,539
men, 1,619 women) in 1997 and 2000, while more
women than men were hospitalized for first ischemic
stroke (11,381 men, 12,150 women) in 1997 and 2000.
General characteristics are provided in Table 1. In all
three groups women were older than men. Men had
more previous admissions for ischemic heart disease
than women. Women were known to have diabetes mel-
litus more often than man. More men were admitted to
academic hospitals than women. This difference was the
most pronounced among PAD patients (men: 11.2%,
women: 7.8%). The length of stay was longer for women
than men. De mean length of stay was clearly the long-
est among ischemic stroke patients. The largest part of
the patients (93% of PAD patients, 94% of ischemic
stroke patients and 95% of AMI patients) were diag-
nosed with an atherosclerotic manifestation at one loca-
tion of the vascular bed (Figure 1). These patients had
n o tb e e np r e v i o u s l ya d m i t t e df o rA M I ,P A Da n d
ischemic stroke.
28-day case fatality
In men, the 28-day case fatality after AMI, PAD and
ischemic stroke was 12.7%, 2.4% and 21.0%, respectively.
In women this was 20.9%, 3.5% and 23.8% (Table 2).
There were large variations in 28-day case fatality in the
different age groups (Table 2). The risk of death in AMI
patients was much higher compared to PAD patients
(men: RR 5.57; 95%CI 4.23 to 7.32, women: RR 6.64;
95%CI 4.99 to 8.84) and lower compared to ischemic
stroke patients (Table 3). In PAD, AMI and ischemic
stroke patients the overall risk of death was higher for
women. However, in the AMI group there were no
longer differences in risk of death between men and
women after adjustment for age (Table 4).
Table 1 Characteristics of patients with a first hospitalization in the Netherlands for acute myocardial infarction (AMI),
peripheral arterial disease of the lower extremities (PAD) and ischemic stroke
AMI# PAD† Ischemic stroke‡
Men Women Men Women Men Women
Number of patients 14,463 7,102 2,539 1,619 11.381 12.150
Age at admission (years)
Mean 64.3 71.9 66.1 66.9 70.2 74.7
Standard deviation 12.3 11.8 11.6 13.9 12.3 13.1
Previous hospitalization for:
cardiovascular disease
17.8 18.5 28.9 25.0 21.4 20.0
- ischemic heart disease 8.1 7.3 13.6 8.6 8.0 5.1
- acute myocardial infarction 0.0 0.0 3.7 3.2 3.2 1.8
- stroke 1.5 1.4 4.6 3.3 0.0 0.0
- peripheral arterial disease 3.1 2.6 0.0 0.0 4.1 2.5
- heart failure 2.1 3.1 3.9 3.5 2.9 3.6
- other cardiovascular disease 6.3 7.5 14.0 15.2 11.6 13.4
diabetes mellitus 6.7 7.2 10.8 13.3 11.1 13.7
Type of hospital (%)
- academic
6.2 5.7 11.2 7.8 11.0 9.2
Length of stay (days) 10 11 4 5 22 27
Origin (%)
-native Dutch
89.3 90.0 91.5 89.5 89.9 88.9
# Cohort is based on patients first hospitalized for AMI in 1995, † Cohort is based on patients first hospitalized for PAD in 1997 or 2000
‡ Cohort is based on patients first hospitalized for ischemic stroke in 1997 or 2000
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Compared to 28-day case fatality, the differences in risk
of death between AMI and PAD patients reduced in all
age-sex-groups (Table 3). In PAD, AMI and ischemic
stroke patients the overall risk of death was higher for
women. However, after adjustment for age there were
no differences in risk of death between men and women
(Table 4).
In men, the 1-year risk of death among patients who
survive for at least 28 days after first admission for
AMI, PAD and ischemic stroke was 6.2%, 9.0% and
10.9%, respectively. In women this was 9.2%, 7.1% and
13.0% (Table 5).
Five-year mortality
In men, the 5-year risk of death after AMI, PAD and
ischemic stroke was 32.2%, 31.0% and 48.6%, respec-
tively. In women this was 44.5%, 27.4% and 53.0%
(Table 2). Although 5-year risk of death was the highest
for ischemic stroke patients, the difference between
1-year and 5-year mortality risks among PAD patients
sharply rises and clearly is the highest, especially among
male PAD patients (Figure 2). In AMI and ischemic
stroke patients the overall risk of death was higher for
women. After adjustment for age the risk of death was
higher in men than in women (age-adjusted hazard ratio
for ischemic stroke, AMI, and PAD: 1.18; 95%CI 1.14 to
1.23, 1.06; 95%CI 1.02 to 1.12, 1.35; 95%CI 1.19 to 1.51
respectively) (Table 4).
In men, the 5-year risk of death among patients who
survive for at least 28 days after first admission for
AMI, PAD and ischemic stroke was 22.3%, 22.9% and
19.5%, respectively. In women this was 29.7%, 24.7% and
39.6% (Table 5).
Risk of death for patients without previous admissions
for CVD
Differences between PAD, AMI and ischemic stroke
patients in the presence of comorbidity may affect rela-
tive risk of death. However, we repeated the analysis,
and computed 28-day case fatality, 1-year and long-term
(5-year) mortality by age and gender according to the
actuarial life table method, excluding those patients with
previous admissions for cardiovascular disease (CVD).
Approximately 18% of AMI patients, 21% of ischemic
stroke patients and 28% of PAD patients were excluded.
The relative risks of death between the groups remained
similar, except for 28-day case fatality, were relative risk
for AMI compared to PAD patients increased (data not
shown).
Figure 1 Diagram of patients first hospitalized for acute myocardial infarction (AMI), ischemic stroke, or peripheral arterial disease of
the lower extremities (PAD). Number of patients diagnosed with atherosclerosis at single or multiple sites of vascular bed.
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Page 4 of 9Table 2 Mortality risk at 28 days, 1 year and 5 years after a first hospital admission for acute myocardial infarction
(AMI), peripheral arterial disease in the lower extremities (PAD) and ischemic stroke, by age and gender
Acute myocardial infarction PAD Ischemic stroke
Age No. of
men
No. of
women
Men Women No. of
men
No. of
women
Men Women No. of
men
No. of
women
Men Women
%
deaths
%
deaths
%
deaths
%
deaths
%
deaths
%
deaths
28-day case
fatality
<55 3,424 656 4.1 5.8 478 339 - - 1,336 1,145 6.8 7.5
55-74 8,027 3,285 10.6 12.8 1,454 778 1.8 1.4 5,549 3,185 14.3 17.2
75-84 2,563 2,346 26.3 29.8 531 385 5.3 5.7 3501 4739 29.2 25.6
85+ 449 815 38.8 40.0 76 117 18.4 18.8 995 2481 47.8 42.3
Total 14,463 7,102 12.7 20.9 2,539 1,619 2.4 3.5 11,381 12,150 21.0 23.8
ASR* 6.0 8.2 0.5 0.5 7.6 9.0
1-year
mortality
<55 3,424 656 5.5 7.3 478 339 2.5 1.5 1,336 1,145 8.9 8.9
55-74 8,027 3,285 15.3 17.9 1,454 778 7.9
18.6
6.3 5,549 3,185 20.9 20.1
75-84 2,563 2,346 37.4 39.1 531 385 47.4 16.6 3501 4739 42.2 36.4
85+ 449 815 56.3 55.6 76 117 10.3 41.0 995 2481 61.7 59.2
Total 14,463 7,102 18.2 28.2 2,539 1,619 3.8 10.4 11,381 12,150 29.6 33.4
ASR* 7.9 9.9 2.1 9.8 11.3
5-years
mortality
<55 3,424 656 9.4 11.6 478 339 8.4 5.0 1,336 1,145 14.7 12.0
55-74 8,027 3,285 29.0 30.0 1,454 778 27.7 21.2 5,549 3,185 37.6 35.3
75-84 2,563 2,346 63.2 60.9 531 385 52.7 45.2 3501 4739 68.2 61.1
85+ 449 815 85.5 81.6 76 117 84.2 74.4 995 2481 86.7 83.5
Total 14,463 7,102 32.2 44.5 2,539 1,619 31.0 27.4 11,381 12,150 48.6 53.0
ASR* 13.7 15.9 13.2 7.2 17.1 15.7
PAD: peripheral arterial disease of the lower extremities
*ASR: age-standardized rates (ASR) adjusted to European Standard
- Number of deaths < 3
Table 3 28-day, 1-year and 5-year risk of death after hospital admission for acute myocardial infarction (AMI)
compared to ischemic stroke or lower extremity arterial disease (PAD)
AMI vs PAD AMI vs ischemic stroke
RR (95%CI)* RR (95%CI)**
28 days 1 year 5 years 28 days 1 year 5 years
Men <55 - 2.20 (1.24-3.91) 1.13 (0.82-1.54) 0.60 (0.43-0.83) 0.62 (0.50-0.77) 0.64 (0.54-0.76)
55-74 9.62 (5.78-16.02) 1.43 (1.22-1.68) 1.04 (0.95-1.14) 0.74 (0.67-0.82) 0.73 (0.68-0.78) 0.77 (0.73-0.81)
75-84 4.99 (3.39-7.36) 2.00 (1.67-2.41) 1.20 (1.10-1.31) 0.90 (0.84-0.97) 0.89 (0.83-0.94) 0.93 (0.89-0.96)
85+ 2.10 (1.21-3.65) 1.19 (0.93-1.53) 1.02 (0.91-1.13) 0.81 (0.73-0.90) 0.91 (0.83-1.00) 0.99 (0.94-1.03)
Total 5.57 (4.23-7.32) 1.76 (1.56-1.98) 1.04 (0.98-1.11) 0.61 (0.57-0.64) 0.61 (0.59-0.64) 0.66 (0.64-0.68)
Women <55 - 4.96 (1.99-12.35) 2.31 (1.39-3.84) 0.77 (0.57-1.05) 0.82 (0.59-1.14) 0.97 (0.74-1.26)
55-74 14.28 (6.68-30.52) 2.84 (2.14-3.76) 1.42 (1.23-1.64) 0.75 (0.66-0.84) 0.75 (0.68-0.82) 0.72 (0.67-0.76)
75-84 5.22 (3.38-8.06) 2.35 (1.87-2.96) 1.35 (1.20-1.51) 1.17 (1.09-1.24) 1.07 (1.01-1.14) 1.00 (0.96-1.04)
85+ 2.13 (1.37-3.29) 1.35 (1.08-1.70) 1.10 (0.98-1.23) 0.95 (0.89-1.01) 0.94 (0.88-1.01) 0.98 (0.94-1.01)
Total 6.64 (4.99-8.84) 2.75 (2.37-3.20) 1.62 (1.49-1.77) 0.83 (0.80-0.88) 0.80 (0.77-0.84) 0.80 (0.77-0.82)
* Relative risk in patient with AMI compared to patient with PAD
** Relative risk in patient with AMI compared to patient with Ischemic stroke
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The present study shows that the dynamics of mortality
over follow-up time clearly differ between patients first
hospitalized for atherosclerotic diseases located at differ-
ent vascular beds. Short-term mortality is the highest
for ischemic stroke patients and the lowest for PAD
patients. However, the risk of death increases consider-
ably over follow-up time for PAD patients, and 5 years
after first hospital admission the differences in risks of
death between AMI- and PAD patients and between
AMI- and ischemic stroke patients have largely
disappeared.
Patients hospitalized for ischemic stroke have the
highest risk of death compared to patients hospitalized
for AMI or PAD. This finding was in agreement with
the study of Caro et al. [8], were they reported crude
five-year death rates of 33.2% and 41.8% for patients
diagnosed with PAD and stroke respectively. Further-
more, they reported lower 5-year mortality risk for AMI
patients (26.6%) than for PAD patients. For women, this
finding is in agreement. For men, however we observed
similar risks of death between AMI and PAD patients.
The higher age of ischemic stroke patients may have
affected risk of death but cannot fully explain the
higher risk of death, as the age-standardized mortality
rates were also higher for thei s c h e m i cs t r o k ep a t i e n t s
(Table 2).
The heart and the brains are vital organs, and distur-
bance of the functioning of these organs may be
reflected in the high case-fatality among patients first
hospitalized for AMI and ischemic stroke. It has been
suggested that apart from the symptomatic atherosclero-
tic lesion, multiple stable or unstable lesions are present
in the whole arterial vessel tree, predicting the patient’s
prognosis [15]. In addition, it has been suggested that
atherosclerotic lesions occur predominantly in the large
vessels first, with distal lesion occurring thereafter [16].
It is therefore likely that patients first hospitalized for
PAD have atherosclerotic lesions in the whole arterial
vessel tree. Our observation that PAD patients had
more previous admissions for cardiovascular diseases
than the AMI and ischemic stroke patients supports this
Table 4 Gender differences in short-term and long-term
mortality after first hospital admission in the
Netherlands for acute myocardial infarction (AMI),
peripheral arterial disease in the lower extremities (PAD)
and ischemic stroke
AMI PAD Ischemic stroke
HR (95%CI)* HR (95%CI)* HR (95%CI)*
Crude
28 day 0.60 (0.56-0.64) 0.67 (0.47-0.96) 0.88 (0.83-0.92)
1 year 0.62 (0.58-0.65) 0.90 (0.81-1.20) 0.87 (0.83-0.91)
5 years 0.66 (0.63-0.69) 1.15 (1.03-1.29) 0.88 (0.85-0.92)
Adjusted†
28 days 0.91 (0.85-0.98) 0.88 (0.61-1.28) 1.11 (1.05-1.18)
1 year 0.96 (0.91-1.02) 1.19 (0.98-1.45) 1.14 (1.08-1.19)
5 years 1.06 (1.02-1.12) 1.35 (1.19-1.51) 1.18 (1.14-1.23)
* Hazard ratio in men compared to women
† Adjusted for age
Table 5 Mortality among patients, who survive for at least 28 days after first hospital admission for acute myocardial
infarction (AMI), peripheral arterial disease in the lower extremities (PAD), or ischemic stroke, by age and gender
Acute myocardial infarction PAD Ischemic stroke
Age No. of
men
No. of
women
Men Women No. of
men
No. of
women
Men Women No. of
men
No. of
women
Men Women
%
deaths
%
deaths
%
deaths
%
deaths
%
deaths
%
deaths
1-year
mortality
<55 3,284 618 1.5 1.7 224 335 5.3 0.9 1,245 1,059 2,3 1,5
55-74 7,177 2,863 5.2 5,7 1,436 769 6.7 5.2 4,754 2,941 7,7 7,3
75-84 1,888 1,646 15.0 13.2 503 363 14.1 11.6 2,478 3,526 18.4 14.6
85+ 275 489 28.7 26.0 62 95 35.5 27.4 519 1,432 26.6 29.3
Total 12,624 5,616 6.2 9,2 2,225 1,532 9.0 7.1 8,996 8,958 10.9 13.0
5-year
mortality
<55 3,284 618 5.6 6.1 224 335 8.4 3.9 1,245 1,059 8,5 4,8
55-74 7,177 2,863 20.5 19.7 1,436 769 26.8 20.2 4,754 2,941 27,1 26,8
75-84 1,888 1,646 50.1 44.3 503 363 49.9 41.9 2,478 3,526 55.0 47.7
85+ 275 489 76.4 69.3 62 95 80.6 68.4 519 1,432 74.6 71.8
Total 12,624 5,616 22.3 29.7 2,225 1,532 22.9 24.7 8,996 8,958 19.5 39.6
PAD: peripheral arterial disease of the lower extremities
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cular disease events and CVD and total mortality has
been demonstrated in multiple studies [17] and under-
lines the importance of secondary prevention among
PAD patients, though PAD patients tend to be under-
treated compared to patients with other manifestations
of atherosclerosis, and it would appear that cardiovascu-
lar risk factor management for prevention in PAD
patients is very modest [18,19]. Therefore, clinicians
should be aware of the dynamics of mortality over fol-
low-up time for patients admitted for different manifes-
tations of atherosclerosis, in order to provide optimal
secondary prevention treatment.
In this study higher age-adjusted 5-year risk of death
after admission for AMI, PAD and ischemic stroke was
observed for men. This is in agreement with findings
from other studies for PAD and ischemic stroke patients
[20,21]. Nevertheless, some factors that may be related
Figure 2 The difference* between 1-year and 5-year risk of death (%) after first hospital admission for acute myocardial infarction
(AMI), peripheral arterial disease of the lower extremities (PAD) or ischemic stroke (IS), by age.
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among men and women. Women were known to be
older, have more diabetes and had a longer mean length
of stay, while men were admitted to academic hospitals
more often and had more previous admissions for
ischemic stroke. Furthermore, other predictors for long-
term risk of death may have been unequally distributed
among men and women in the present study, thereby
affecting the risk of death. For example, the prevalence
of smoking, which is a risk factor for progression of
atherosclerosis [8], is generally higher among men
[22,23]. Smoking reduces survival in patients with ather-
osclerosis [24], and therefore smoking behavior might
affect our results through over-estimation of the gender
differences in mortality risk. Unfortunately, our study
does not permit an in-depth evaluation of these esti-
mates, since no information was available for most of
the known predictors for prognosis following ischemic
stroke, AMI and PAD.
Strengths and limitations
The strength of our study is the large size of the cohort,
obtained from usual care, with a large age range and
information on both men and women. Even though the
validity of national registers has been questioned, several
studies have shown that for the Netherlands the validity
is adequate [25,26] and a high validity of the linkage
between the registers has been demonstrated [26,27].
Furthermore, for ICD-9 codes 410, 434 and 436, the
positive predictive values have been shown to be accep-
table [28-30].
To appreciate the findings, the following needs con-
sideration. The limitation of previous admissions to a
maximum of 6 years may have resulted in some “first-
time” AMI, PAD or ischemic stroke patients (especially
those older than 65 years) who were actually returning
patients. The inclusion of returning patients may cause
overestimation of absolute mortality rates (as returning
patients are usually more severe patients), but not
affect the difference between men and women, as there
is no difference in return rate between men and
women [31-33].
Mortality risks presented in this study are based on
AMI patients hospitalized in 1995 and stroke and PAD
patients hospitalized in 1997/2000. However there is a
substantial change in the way patients are treated now a
day (especially AMI patients) and as a result of that cur-
rent mortality risks may be lower.
Finally, the number of PAD patients was considerable
smaller than the number of AMI and ischemic stroke
patients. This is due to the fact that we decided to use
ICD-9 code 443.9 for the identification of patients with
peripheral arterial disease of the lower extremities
(this code is described as peripheral vascular disease
unspecified, intermittent claudication not otherwise spe-
cified). The PAD cohort would be much larger if we
also used ICD-9 code 440.2 (atherosclerosis of the extre-
mities), ICD-9 code 444.22 (arterial embolism or throm-
bosis of the lower extremities) and ICD-9 code 785.4
(gangrene). However, the PAD cohort would also
become a case mix of patients with large differences in
severity, symptoms and prognosis. Therefore only
patients with ICD-9 code 443.9, representing moderate/
severe claudication patients (Fontaine stage IIb, III and
IV respectively) were included in this study. The ICD-9
codes 440.2, 444.22 and 785.4 may represent the more
severe forms of the disease compared to moderate/
severe claudication patients. Therefore, the risk of death
after admission among these PAD patients is probably
higher than observed risk of death presented in this
study.
Conclusions
The present study shows that the dynamics of mortality
over follow-up time clearly differ between patients first
hospitalized for atherosclerotic diseases located at differ-
ent vascular beds. Short-term mortality is the highest in
ischemic stroke patients and the lowest for PAD
patients. However, the risk of death increases consider-
ably over follow-up time for PAD patients, and 5 years
after first hospital admission the differences in risks
of death between AMI- and PAD patients and between
AMI- and ischemic stroke patients have largely
disappeared.
Clinicians should be aware of the dynamics of mortal-
ity over follow-up time for patients admitted for differ-
ent manifestations of atherosclerosis, in order to provide
optimal secondary prevention treatment.
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